Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Jul;71(1):55-7.
doi: 10.1590/s0066-782x1998000700010.

[Antihypertensive treatment. Prescription and cost of drugs. Survey in a tertiary care hospital]

[Article in Portuguese]
Affiliations

[Antihypertensive treatment. Prescription and cost of drugs. Survey in a tertiary care hospital]

[Article in Portuguese]
D Akashi et al. Arq Bras Cardiol. 1998 Jul.

Abstract

Purpose: To study the most prescribed anti-hypertensive drugs, evaluating their agreement with established guidelines and drug cost.

Methods: One hundred and forty one (101 women, mean age = 53.3 years) hypertensive patients who searched spontaneous attention were interviewed in a tertiary-care hospital. The inclusion criteria were previous diagnosis of hypertension and non cardiovascular complaints.

Results: The majority of the 107 (75.9%) patients were on medical treatment. In those receiving monotherapy, thiazides were the most utilized drugs, followed by methyldopa, ACE inhibitors, calcium channel-blockers, and beta-blockers. The association with thiazides (26.3%) followed the same preference. The second most prescribed drug, methyldopa, was the more expensive. Fifty percent of the patients purchased the drugs at their own expense.

Conclusion: A preference for prescription of expensive drugs for hypertension was detected in this sample in Brazil. This does not agree with major guidelines, mainly the V-JNC, which suggest thiazides and betablockers as first choice drugs for hypertensives with no complications or associated comorbidity.

PubMed Disclaimer

Publication types

Substances

LinkOut - more resources